• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风病眼部病变的进展:荷兰的十年随访研究。

Progression of eye lesions in leprosy: ten-year follow-up study in The Netherlands.

作者信息

Hogeweg M, Faber W R

机构信息

Department of Ophthalmology, Erasmus University Rotterdam, The Netherlands.

出版信息

Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):392-7.

PMID:1890362
Abstract

Forty-eight leprosy patients in The Netherlands were re-examined 10 years after initial examination. Forty-six of these patients had received a course of multidrug therapy (MDT), according to the World Health Organization recommendation, at the time of their initial examination. Two patients had burned-out disease and had been merely under observation. Out of 40 patients, who initially did not show eye complications due to leprosy, 37 patients were essentially the same 10 years later. The eyes had changed in 3 multibacillary patients: 1 patient had developed a late type 1 reaction with facial nerve involvement and lagophthalmos; 2 patients had undergone intra-ocular surgery for cataract and acute glaucoma, respectively. Out of 8 patients with pre-existing eye involvement, 1 patient recovered and the lesions in 2 patients remained unaltered. One patient showed progression of pre-existing exposure keratitis. Four patients had undergone cataract extractions; all four patients were lepromatous, with a long history of disease and signs of iris involvement at the first examination. The main progressive lesions were cataracts in lepromatous patients.

摘要

荷兰的48名麻风病患者在初次检查10年后接受了复查。其中46名患者在初次检查时已按照世界卫生组织的建议接受了多药联合治疗(MDT)疗程。2名患者病情已无活动,仅接受观察。在最初未表现出麻风病眼部并发症的40名患者中,37名患者在10年后基本情况相同。3名多菌型患者的眼睛出现了变化:1名患者发生了伴有面神经受累和兔眼的迟发型1型反应;2名患者分别接受了白内障和急性青光眼的眼内手术。在8名既往有眼部受累的患者中,1名患者康复,2名患者的病变保持不变。1名患者先前存在的暴露性角膜炎病情进展。4名患者接受了白内障摘除手术;所有4名患者均为瘤型麻风,病程长,初次检查时有虹膜受累迹象。主要的进行性病变是瘤型麻风患者的白内障。

相似文献

1
Progression of eye lesions in leprosy: ten-year follow-up study in The Netherlands.麻风病眼部病变的进展:荷兰的十年随访研究。
Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):392-7.
2
Ocular manifestation in treated multibacillary Hansen's disease.经治疗的多菌型麻风病的眼部表现。
Ophthalmology. 2009 Nov;116(11):2051-7.e1. doi: 10.1016/j.ophtha.2009.04.021. Epub 2009 Sep 19.
3
Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.印度南部新发病例、复发的界线类偏瘤型和瘤型麻风患者的眼部并发症
Indian J Ophthalmol. 2003 Jun;51(2):155-9.
4
Intraocular lens implantation in leprosy.麻风病患者的人工晶状体植入术。
Int J Lepr Other Mycobact Dis. 2002 Mar;70(1):9-15.
5
Frequency of ocular complications of leprosy in institutionalized patients in NWFP Pakistan.
J Ayub Med Coll Abbottabad. 2002 Oct-Dec;14(4):29-33.
6
Short-term follow up of patients with multibacillary leprosy and HIV infection.多菌型麻风病合并HIV感染患者的短期随访
Int J Lepr Other Mycobact Dis. 1996 Dec;64(4):392-5.
7
New lesions after MDT in PB and MB leprosy: a report of 28 cases.多药联合治疗后PB型和MB型麻风病出现新皮损:28例报告
Indian J Lepr. 2008 Jul-Sep;80(3):247-55.
8
The prevalence of disabling ocular complications of leprosy: a global study.麻风病致盲性眼部并发症的患病率:一项全球研究。
Indian J Lepr. 1998 Jan-Mar;70(1):49-59.
9
Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.12个月的世界卫生组织/多药联合治疗麻风病方案与结核分枝杆菌疫苗联合用于多菌型麻风病:136例患者的随访
Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):174-81.
10
Cataract surgery in a leprosy population in Liberia.
Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):20-4.

引用本文的文献

1
Progression of eye disease in "cured" leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eyecare needs.“治愈”麻风病患者眼部疾病的进展:对理解眼部疾病病理生理学及满足眼保健需求的意义
Br J Ophthalmol. 2000 Aug;84(8):817-21. doi: 10.1136/bjo.84.8.817.